From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

Item
http://www.wikidata.org/entity/Q34084150
Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome AgentsA rapid LC-MS/MS method for quantification of CSUOH0901, a novel antitumor agent, in rat plasma.A New Ligustrazine Derivative-Selective Cytotoxicity by Suppression of NF-κB/p65 and COX-2 Expression on Human Hepatoma Cells. Part 3Identification of selective tubulin inhibitors as potential anti-trypanosomal agentsA Simple and Rapid LC-MS/MS Method for the Determination of BMCL26 a Novel Anti-Parasitic Agent in Rat PlasmaSynthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors.Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host.Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.Synthesis and biological evaluation of selective tubulin inhibitors as anti-trypanosomal agents.Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.Synthesis and Biological Evaluation of Novel Indomethacin Derivatives as Potential Anti-Colon Cancer Agents.MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2.Effects of celecoxib on cell apoptosis and Fas, FasL and Bcl-2 expression in a BGC-823 human gastric cancer cell line.Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor AgentsNimesulide Based Novel Glycolamide Esters: Their Design, Synthesis, and Pharmacological Evaluation
P2860

From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

Item
http://www.wikidata.org/entity/Q34084150
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@ast
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@en
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@nl
type
label
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@ast
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@en
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@nl
prefLabel
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@ast
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@en
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
From COX-2 inhibitor nimesulid ...... nd pharmacokinetic evaluation.
@en
P2093
P2860
P304
P31
P356
10.1016/J.EJMECH.2011.11.012
P433
P478
P577
P698
P932